Cargando…
Generation of Antibody-Drug Conjugate Resistant Models
SIMPLE SUMMARY: Antibody-drug conjugates (ADCs) constitute new and effective therapies in cancer. However, resistance is frequently observed in treated patients after a given period of time. That resistance may be present from the beginning of the treatment (primary or de novo resistance) or raise a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466899/ https://www.ncbi.nlm.nih.gov/pubmed/34572858 http://dx.doi.org/10.3390/cancers13184631 |